Epithalon Research

Epithalon (Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Dr. Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It is studied for its potential influence on telomerase activity and cellular aging research pathways.

Research Areas

Telomerase Activity Research

Studies by Khavinson et al. investigated Epithalon's ability to activate telomerase enzyme in human somatic cells, examining its potential influence on telomere length maintenance in the context of cellular aging research.

↗ Khavinson et al. 2003 — Epithalon and telomerase activation

Pineal & Circadian Signaling

Research explores Epithalon's relationship to melatonin production and pineal gland function in aging subjects, examining circadian signaling pathway changes associated with the aging pineal gland.

Cellular Senescence Research

Preclinical studies examine Epithalon's effects on cellular senescence markers, oxidative stress-related signaling, and longevity-associated gene expression pathway research.

Hormonal Axis Regulation Research

Research has investigated Epithalon's effects on hypothalamic-pituitary axis signaling and melatonin/cortisol rhythm research in aging study populations.

Investigational compound in cellular aging research; most published studies are preclinical or from a small number of research groups.

Research References